Moneycontrol PRO
you are here: HomeNewsTrendsHealth

Reinfection with different subtypes of Omicron possible, study finds

With the surge of Omicron subvariants BA.1 and BA.2, a large number of reinfections from earlier cases have been observed, the researchers said.

February 23, 2022 / 05:27 PM IST
Image Source: Reuters

Image Source: Reuters

Reinfection with the BA.2 subtype of the Omicron variant of coronavirus can occur shortly after initial infection with the BA.1 strain, according to a Danish study.

With the surge of Omicron subvariants BA.1 and BA.2, a large number of reinfections from earlier cases have been observed, the researchers said.

This has raised questions of whether BA.2 specifically can escape the natural immunity acquired shortly after a BA.1 infection, they said.

The researchers from Statens Serum Institut (SSI) in Denmark selected a subset of samples from over 1.8 million cases of infections in the period from November 22, 2021, until February 11, 2022.

The yet-to-be peer-reviewed study, posted on the preprint repository MedRxiv on Tuesday, identified a total of 187 reinfection cases.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The researchers found 67 cases in which the same individual had become infected twice at a 20-60-day interval, and where both infections were due to Omicron subtypes.

In 47 of the cases, the affected individual first became infected by BA.1 and then by BA.2, they said.

The majority of the infected were young and unvaccinated, and most experienced mild symptoms during their infections, according to the researchers.

The team noted that the difference between the severity during their first and second infection was negligible. None of the infected individuals had become seriously ill, and none required admission to hospital, they said.

None of the infected individuals had become seriously ill, and none required admission to hospital, they said.

"The study shows that infection with two different Omicron subtypes is possible,” the authors of the study noted.

"This seems to occur relatively rarely in Denmark, and reinfections have mainly affected younger unvaccinated individuals, they added.

PTI
first published: Feb 23, 2022 05:27 pm